1Lomitapide mesylate, a novel drug for familial hypercholesterolemiaZHANG Xu-yang, LIU Bing-ni, LIU Deng-ke, WANG Ping-bao2093-2095,21002Introduction of biosimilarity product policy in USALI Wei, BAI Yu2096-21003The strategy of U.S.patent protection about lipid-lowering drug atorvastatinMAO Jin-long, LIN Cui-xia, SUN Rong2101-21054Structural alerts of genotoxic impuritiesMA Lei, MA Yu-nan, CHEN Zhen, JIANG Yu2106-21115Requirements and common issues of genotoxicity study for pharmaceuticalsHUANG Fang-hua, WANG Qing-li2112-21166Establishment of a histopathology evaluation method of in vivo neurovirulence test in monkeys2117-21227Advances in absorbable hemostatic materials and their safety evaluationZHOU Wei, ZHANG Li, GUO Jia-bin, ZHAO Jun, PENG Shuang-qing2123-21268Studies on the related substance of near period recombinant human growth hormone in two different formsLI Jing, CHENG Su-yuan, ZHANG Hui, LIANG Cheng-gang2127-2131,21439Evolution of medicines and healthcare products regulatory agencyYAO Li-xin2132-214310Establishment and validation of an ELISA method for quantitation of 13 serotype-specific anti-pneumococcal IgG antibodies in mouse serum2144-2149,216011The research status and prospect of cancer chemoprevention by Chinese medical materialsZOU Jian-ming, ZHANG Ying2150-215412Advances in animal models of Parkinson's diseaseSUN Tao2155-216013Advances in drug therapy for wet age-related macular degenerationSHI Wei-feng, GUI Cheng, LI Xiao-yu, LIU Gao-lin2161-216414Silent genes provide new ideas for microbial pharmaceutical researchSHENG Nan, GU Jue-fen2165-2168,218415Development of 11β-HSD1 inhibitors for metabolic syndromeXIANG Qing, XU Wen, HUANG Ming-qing, LIN Yuan2169-217316Cost-effectiveness of insulin aspart and human soluble insulin for treatment of type 2 diabetesXU Zhang-rong, JI Qiu-he, XU Fei, YE Qing2174-217917The influence of CYP2C19 gene polymorphism on efficacy of combinational antiplatelet therapy for cerebral small vessel diseaseLIANG Xue-mei, TIAN Ming-xiu2180-218418Effects of β-asarone on neuroplasticity-related factors in hippocampus of rat model of depressionRONG Hua, DONG Hai-ying, GAO Zhi-ying, ZHANG Jing-yan, ZHANG Xiao-jie2185-2188,219419Synthesis, activity testing and mechanism exploration of 3-hydroxy-3-(5-chloro-2-hydroxyphenyl) propionyl-hydroxamic acids as Helicobacter pylori urease inhibitorDENG Rui-cheng, WEI Wei, WANG Xu-dong, XIAO Zhu-ping2189-219420Synthesis and antidiabetic activities of novel pyrrolotriazine compounds as DPP-4 inhibitorsLI Cui-juan, LE Zhi-ping, ZHAO Chuan-sheng2195-2202 